🚀 Cleancard: Your Health's Best Friend 🚀

Think pregnancy test. But for cancer. BOOM!

đź’ˇ The Gist

Ever thought of a world where cancer screening is as simple as taking a pregnancy test?

Well, Cleancard's got the memo.

By blending SynBio with AI, we're introducing a no-fuss, reliable at-home cancer diagnostic. No more agonizing waits—just results in 30 minutes.

🎤 Roll Call - The Oxford Giants

Tom and Luca, the co-founders, are Rhodes Scholars. And their not just smart, but highly driven.

Let's get personal:

👨🏻 Tom: The clinical cancer research maverick. Bioinformatics? He's acing it. Biomarker tests? He's revolutionizing 'em.

👨🏻‍🦰 Luca: When algorithms meet healthcare policy, that's Luca's jam. With a history of bolstering healthtech and consumer startups, he's channeling all that mojo into Cleancard.

🚨 Health Check

There are 18M Americans with cancer today.

That's poised to balloon to a whopping 26M by 2040.

1 in 3 folks have a family ghost of cancer, making their own battles more probable.

This isn't just data—it's personal.

Tom and Luca have seen the dark shadows of cancer up close.

The mission?

Early detection to save lives.

đź’Ą Here's The Problem

Cancer's cunning.

Its symptoms play coy, often revealing themselves when it's pretty late in the game

Lab tests? Sure, if you've got time and money to spare.

Dream of at-home tests? They're quick but can be flimsy.

We need trusty, nimble, and sharp solutions. Yesterday.

🚀 Cleancard to the Rescue: Revolutionary Rapid-Test

All it needs is a urine sample. 30 minutes later? Knowledge. Power. Peace of mind.

💸 Beats lab tests in speed and price—by 10 times!

🔍 It's 10x more precise than the current rapid tests.

đź›  Bid adieu to hulking machines and tedious samples.

It's like a superhero movie but for healthcare. Synthetic biology teams up with machine learning and computer vision.

The goal? Spot a multitude of cancer biomarkers from just one sample.

đźš—The Road Ahead

Cleancard is starting with prostate, bladder, and ovarian screens.

But hold your horses—10 more cancer biomarkers joined the fray during their recent YC batch.

And they’re not hitting the brakes.

Cleancard isn't just about tech or tests—it's a revolution.

A beacon of hope.

Your home becomes a sentinel against cancer's sneak attacks.

With Cleancard, we may be just able to tilt the odds in our favor.